Globus Medical Affirms FY2026 Adj EPS Guidance of $4.95-$5.05 vs $5.00 Est; Lowers FY2026 Sales Guidance from $3.180B-$3.220B to $3.090B vs $3.199B Est
Benzinga Newsdesk 4 hours ago
NewsGuidance
Globus Medical (NYSE:GMED) affirms FY2026 Adj EPS guidance from $4.95-$5.05 to $4.95-$5.05 vs $5.00 analyst estimate. Lowers FY2026 sales outlook from $3.180 billion-$3.220 billion to $3.090 billion vs $3.199 billion
Globus Medical (NYSE:GMED) affirms FY2026 Adj EPS guidance from $4.95-$5.05 to $4.95-$5.05 vs $5.00 analyst estimate. Lowers FY2026 sales outlook from $3.180 billion-$3.220 billion to $3.090 billion vs $3.199 billion estimate.